These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29993249)

  • 21. Identification of novel androgen receptor antagonists using structure- and ligand-based methods.
    Li H; Ren X; Leblanc E; Frewin K; Rennie PS; Cherkasov A
    J Chem Inf Model; 2013 Jan; 53(1):123-30. PubMed ID: 23278403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.
    Jehle K; Cato L; Neeb A; Muhle-Goll C; Jung N; Smith EW; Buzon V; Carbó LR; Estébanez-Perpiñá E; Schmitz K; Fruk L; Luy B; Chen Y; Cox MB; Bräse S; Brown M; Cato AC
    J Biol Chem; 2014 Mar; 289(13):8839-51. PubMed ID: 24523409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine Disruption at the Androgen Receptor: Employing Molecular Dynamics and Docking for Improved Virtual Screening and Toxicity Prediction.
    Wahl J; Smieško M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.
    Askew EB; Gampe RT; Stanley TB; Faggart JL; Wilson EM
    J Biol Chem; 2007 Aug; 282(35):25801-16. PubMed ID: 17591767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation of histidine 874 in the androgen receptor ligand-binding domain leads to promiscuous ligand activation and altered p160 coactivator interactions.
    Duff J; McEwan IJ
    Mol Endocrinol; 2005 Dec; 19(12):2943-54. PubMed ID: 16081517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of HO-/MeO-PBDEs on androgen receptor: in vitro investigation and helix 12-involved MD simulation.
    Wang X; Yang H; Hu X; Zhang X; Zhang Q; Jiang H; Shi W; Yu H
    Environ Sci Technol; 2013 Oct; 47(20):11802-9. PubMed ID: 24044724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-parameter imaging assay identifies different stages of ligand-induced androgen receptor activation.
    van Royen ME; van de Wijngaart DJ; Cunha SM; Trapman J; Houtsmuller AB
    Cytometry A; 2013 Sep; 83(9):806-17. PubMed ID: 23585273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
    Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
    Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling androgen receptor flexibility: a binding mode hypothesis of CYP17 inhibitors/antiandrogens for prostate cancer therapy.
    Gianti E; Zauhar RJ
    J Chem Inf Model; 2012 Oct; 52(10):2670-83. PubMed ID: 22924551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational Assessment of Combination Therapy of Androgen Receptor-Targeting Compounds.
    Fischer A; Häuptli F; Lill MA; Smieško M
    J Chem Inf Model; 2021 Feb; 61(2):1001-1009. PubMed ID: 33523669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
    He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
    J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtle structural changes in tetrahydroquinolines, a new class of nonsteroidal selective androgen receptor modulators, induce different functions.
    Nagata N; Kawai K; Nakanishi I
    J Chem Inf Model; 2012 Aug; 52(8):2257-64. PubMed ID: 22794275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
    Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
    Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cheminformatics Modeling of Adverse Drug Responses by Clinically Relevant Mutants of Human Androgen Receptor.
    Paul N; Carabet LA; Lallous N; Yamazaki T; Gleave ME; Rennie PS; Cherkasov A
    J Chem Inf Model; 2016 Dec; 56(12):2507-2516. PubMed ID: 28024400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A surface on the androgen receptor that allosterically regulates coactivator binding.
    Estébanez-Perpiñá E; Arnold LA; Nguyen P; Rodrigues ED; Mar E; Bateman R; Pallai P; Shokat KM; Baxter JD; Guy RK; Webb P; Fletterick RJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16074-9. PubMed ID: 17911242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays.
    Pang JP; Shen C; Zhou WF; Wang YX; Shan LH; Chai X; Shao Y; Hu XP; Zhu F; Zhu DY; Xiao L; Xu L; Xu XH; Li D; Hou TJ
    Acta Pharmacol Sin; 2022 Jan; 43(1):229-239. PubMed ID: 33767381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.
    Hodgson MC; Shen HC; Hollenberg AN; Balk SP
    Mol Cancer Ther; 2008 Oct; 7(10):3187-94. PubMed ID: 18852122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
    Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
    Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of Novel Anti-Resistance AR Antagonists Guided by Funnel Metadynamics Simulation.
    Chen H; Zhou Y; Wang X; Chai X; Wang Z; Wang E; Xu L; Hou T; Li D; Duan M
    Adv Sci (Weinh); 2024 May; 11(19):e2309261. PubMed ID: 38481034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of the homodimeric androgen receptor ligand-binding domain.
    Nadal M; Prekovic S; Gallastegui N; Helsen C; Abella M; Zielinska K; Gay M; Vilaseca M; Taulès M; Houtsmuller AB; van Royen ME; Claessens F; Fuentes-Prior P; Estébanez-Perpiñá E
    Nat Commun; 2017 Feb; 8():14388. PubMed ID: 28165461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.